Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity”

6,133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,133 results

Testing effectiveness (Phase 2)Study completedNCT05868382
What this trial is testing

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 270
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Early research (Phase 1)Study completedNCT03038776
What this trial is testing

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Who this might be right for
Influenza, Avian
Vaxine Pty Ltd 150
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Large-scale testing (Phase 3)Study completedNCT02545543
What this trial is testing

Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age

Who this might be right for
Influenza, Human
Seqirus 2,278
Post-approval studies (Phase 4)UnknownNCT04638985
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Who this might be right for
Vaccine
China National Biotec Group Company Limited 600
Early research (Phase 1)Study completedNCT02531685
What this trial is testing

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT00971425
What this trial is testing

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Who this might be right for
Influenza
GlaxoSmithKline 145
Early research (Phase 1)Study completedNCT02639091
What this trial is testing

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Who this might be right for
Medical Oncology
Bayer 36
Not applicableStudy completedNCT01304810
What this trial is testing

A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

Who this might be right for
Smoking CessationNicotine Dependence
Nabi Biopharmaceuticals 300
Early research (Phase 1)Active Not RecruitingNCT07428759
What this trial is testing

Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 121
Testing effectiveness (Phase 2)Study completedNCT00924170
What this trial is testing

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Who this might be right for
Adult T-Cell Leukemia (ATL)
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT05572879
What this trial is testing

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Who this might be right for
COVID-19
EuBiologics Co.,Ltd 2,600
Not applicableStudy completedNCT02398396
What this trial is testing

Investigating Meningococcal Vaccines in Adults

Who this might be right for
Meningococcal VaccinesMeningococcal InfectionsNeisseria Meningitidis+1 more
University of Oxford 15
Early research (Phase 1)Study completedNCT04142086
What this trial is testing

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults

Who this might be right for
Yellow Fever (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 73
Early research (Phase 1)Study completedNCT02337855
What this trial is testing

A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults

Who this might be right for
Schistosomiasis
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00289185
What this trial is testing

Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 340
Testing effectiveness (Phase 2)Study completedNCT02313155
What this trial is testing

Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Who this might be right for
Influenza Infection
Takeda 110
Testing effectiveness (Phase 2)Study completedNCT02546960
What this trial is testing

A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860

Who this might be right for
Healthy
Janssen Research & Development, LLC 848
Early research (Phase 1)Study completedNCT04188691
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

Who this might be right for
Norwalk GastroenteritisNorovirus Infections
National Vaccine and Serum Institute, China 510
Load More Results